Zimmer Biomet Holdings ROE 2006-2019 | ZBH
Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending June 30, 2019 was 13.40%.
| Zimmer Biomet Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2019-06-30 | $-0.36B | $11.66B | -3.07% |
| 2019-03-31 | $-0.31B | $11.54B | -2.62% |
| 2018-12-31 | $-0.38B | $11.28B | -3.19% |
| 2018-09-30 | $1.75B | $12.22B | 14.61% |
| 2018-06-30 | $1.69B | $12.04B | 14.62% |
| 2018-03-31 | $1.69B | $12.00B | 15.19% |
| 2017-12-31 | $1.81B | $11.74B | 17.10% |
| 2017-09-30 | $0.65B | $10.45B | 6.47% |
| 2017-06-30 | $0.71B | $10.28B | 7.19% |
| 2017-03-31 | $0.50B | $9.93B | 5.11% |
| 2016-12-31 | $0.31B | $9.67B | 3.18% |
| 2016-09-30 | $0.36B | $9.75B | 3.75% |
| 2016-06-30 | $0.23B | $9.55B | 2.32% |
| 2016-03-31 | $0.08B | $9.66B | 0.85% |
| 2015-12-31 | $0.15B | $9.89B | 1.60% |
| 2015-09-30 | $0.17B | $9.99B | 2.02% |
| 2015-06-30 | $0.32B | $10.13B | 4.28% |
| 2015-03-31 | $0.67B | $6.58B | 10.26% |
| 2014-12-31 | $0.72B | $6.55B | 11.19% |
| 2014-09-30 | $0.83B | $6.54B | 12.96% |
| 2014-06-30 | $0.81B | $6.45B | 12.86% |
| 2014-03-31 | $0.78B | $6.24B | 12.75% |
| 2013-12-31 | $0.78B | $6.30B | 12.98% |
| 2013-09-30 | $0.68B | $6.14B | 11.49% |
| 2013-06-30 | $0.70B | $5.89B | 12.05% |
| 2013-03-31 | $0.77B | $5.71B | 13.23% |
| 2012-12-31 | $0.76B | $5.87B | 13.11% |
| 2012-09-30 | $0.76B | $5.83B | 13.38% |
| 2012-06-30 | $0.77B | $5.71B | 13.76% |
| 2012-03-31 | $0.76B | $5.66B | 13.38% |
| 2011-12-31 | $0.76B | $5.52B | 13.25% |
| 2011-09-30 | $0.64B | $5.61B | 11.01% |
| 2011-06-30 | $0.64B | $6.02B | 10.89% |
| 2011-03-31 | $0.60B | $5.86B | 10.37% |
| 2010-12-31 | $0.60B | $5.77B | 10.36% |
| 2010-09-30 | $0.72B | $5.82B | 12.52% |
| 2010-06-30 | $0.68B | $5.74B | 11.72% |
| 2010-03-31 | $0.72B | $5.71B | 12.45% |
| 2009-12-31 | $0.72B | $5.64B | 12.48% |
| 2009-09-30 | $0.73B | $5.98B | 12.70% |
| 2009-06-30 | $0.80B | $5.81B | 14.05% |
| 2009-03-31 | $0.81B | $5.56B | 14.54% |
| 2008-12-31 | $0.85B | $5.65B | 15.10% |
| 2008-09-30 | $0.95B | $5.62B | 16.96% |
| 2008-06-30 | $0.78B | $5.51B | 14.15% |
| 2008-03-31 | $0.78B | $5.71B | 14.38% |
| 2007-12-31 | $0.77B | $5.45B | 14.67% |
| 2007-09-30 | $0.76B | $5.25B | 14.68% |
| 2007-06-30 | $0.89B | $5.28B | 17.75% |
| 2007-03-31 | $0.86B | $5.12B | 17.47% |
| 2006-12-31 | $0.84B | $4.92B | 17.09% |
| 2006-09-30 | $0.79B | $4.80B | 16.37% |
| 2006-06-30 | $0.78B | $4.90B | 16.33% |
| 2006-03-31 | $0.77B | $4.92B | 16.64% |
| 2005-12-31 | $0.73B | $4.68B | 16.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $28.674B | $7.933B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $148.939B | 20.91 |
| Abbott Laboratories (ABT) | United States | $147.101B | 27.65 |
| Stryker (SYK) | United States | $82.696B | 28.60 |
| Boston Scientific (BSX) | United States | $59.981B | 29.09 |
| Baxter (BAX) | United States | $44.653B | 27.08 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $31.497B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.863B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.834B | 41.24 |
| Terumo (TRUMY) | Japan | $23.226B | 26.71 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.906B | 0.00 |
| ResMed (RMD) | United States | $19.182B | 36.58 |
| Sunny Optical Technology (SNPTF) | China | $16.804B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.124B | 54.27 |
| Insulet (PODD) | United States | $9.197B | 544.96 |
| Canopy Growth (CGC) | Canada | $9.163B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.388B | 13.61 |
| William Demant Holdings (WILYY) | Denmark | $7.386B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.984B | 20.82 |
| Haemonetics (HAE) | United States | $6.525B | 49.24 |
| GN STORE NORD (GNNDY) | Denmark | $5.570B | 28.78 |
| Aurora Cannabis (ACB) | Canada | $5.265B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.167B | 0.00 |
| Neogen (NEOG) | United States | $4.002B | 66.44 |
| NuVasive (NUVA) | United States | $3.387B | 27.00 |
| ICU Medical (ICUI) | United States | $3.307B | 21.45 |
| Hutchison China MediTech (HCM) | China | $2.719B | 0.00 |
| Quidel (QDEL) | United States | $2.651B | 26.33 |
| Agios Pharmaceuticals (AGIO) | United States | $2.117B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.015B | 43.49 |
| Cardiovascular Systems (CSII) | United States | $1.761B | 0.00 |
| Aphria (APHA) | $1.519B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.090B | 25.12 |
| AtriCure (ATRC) | United States | $1.008B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.003B | 26.37 |
| Omeros (OMER) | United States | $0.896B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.881B | 14.34 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.802B | 20.45 |
| NanoString Technologies (NSTG) | United States | $0.801B | 0.00 |
| Cerus (CERS) | United States | $0.745B | 0.00 |
| PetIQ (PETQ) | United States | $0.730B | 17.25 |
| LeMaitre Vascular (LMAT) | United States | $0.709B | 42.01 |
| MacroGenics (MGNX) | United States | $0.636B | 0.00 |
| Surmodics (SRDX) | United States | $0.620B | 117.92 |
| TG Therapeutics (TGTX) | United States | $0.607B | 0.00 |
| Quanterix (QTRX) | United States | $0.599B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.462B | 21.40 |
| Meridian Bioscience (VIVO) | United States | $0.407B | 12.71 |
| BioLife Solutions (BLFS) | United States | $0.396B | 130.13 |
| Utah Medical Products (UTMD) | United States | $0.368B | 26.98 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.351B | 0.00 |
| Owens & Minor (OMI) | United States | $0.349B | 10.47 |
| Zynex (ZYXI) | United States | $0.315B | 33.45 |
| United Health Products (UEEC) | United States | $0.270B | 0.00 |
| Bovie Medical (APYX) | United States | $0.247B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.207B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.178B | 0.00 |
| Vapotherm (VAPO) | United States | $0.174B | 0.00 |
| Chimerix (CMRX) | United States | $0.143B | 0.00 |
| Fonar (FONR) | United States | $0.142B | 10.11 |
| Chembio Diagnostics (CEMI) | United States | $0.122B | 0.00 |
| Female Health (VERU) | United States | $0.122B | 0.00 |
| United-Guardian (UG) | United States | $0.085B | 20.07 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| Surface Oncology (SURF) | United States | $0.056B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.033B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.019B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.008B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
